Market Overview:
The global cell separation technologies market reached a value of US$ 7.62 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 19.28 Billion by 2027, exhibiting a growth rate (CAGR) of 16.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Cell separation technologies are a set of techniques, which are extensively deployed for identifying and separating one or more cells from the heterogeneous mixture based on their extracellular properties. They are further utilized in the healthcare sector for dealing with various chronic diseases, such as cancer, acquired immune deficiency syndrome (AIDS) and cystic fibrosis. Some of the most employed techniques for cell separation include microfluidic cell sorting, immunogenicity cell isolation and density gradient configuration. These techniques are applied based on the varying size, density, surface protein expression and shape of the cells.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Cell Separation Technologies Market Trends:
The widespread adoption of cell separation technologies in the pharmaceutical industry to enhance drug discovery and develop drugs with improved efficacies is one of the key factors driving the global cell separation technologies market toward growth. Additionally, the introduction of advanced isolation tools for the continuous examination of nucleic acids, chromatin, proteins, and other complex cells is contributing to the market growth. In line with this, the increasing requirement for personalized medicines and an enhanced focus on cell-based research are positively impacting the market growth. Moreover, the increasing investments and fundings in the research and development (R&D) activities in the field of biotechnology for developing and utilizing isolated cells for developing novel cell-based treatments and therapies for several chronic ailments is propelling the market growth. Furthermore, the escalating prevalence of various chronic diseases amongst the geriatric population is positively influencing the market. Other factors, such as the rapid expansion in the pharmaceutical and biotechnology industry and the numerous initiatives undertaken by the governments of several nations for fortifying the healthcare infrastructure by enhancing cell-based technology, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell separation technologies market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, cell type, technology, application and end user.
Breakup by Product:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Breakup by Cell Type:
Breakup by Technology:
- Centrifugation-based Cell Separation
- Surface marker-based Cell Separation
- Filtration-based Cell Separation
Breakup by Application:
- Oncology Research
- Neuroscience Research
- Stem Cell Research
- Microbiology
- Immunology Research
- Others
Breakup by End User:
- Research Laboratories and Institute
- Biotechnology and Biopharmaceutical Companies
- Cell Banks
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2021 |
Historical Period |
2016-2021 |
Forecast Period |
2022-2027 |
Units |
US$ Billion |
Segment Coverage |
Product, Cell Type, Technology, Application, End User, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Akadeum Life Sciences, Alfa Laval AB, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Corning Incorporated, Merck KGaA, Miltenyi Biotec Inc., PerkinElmer Inc., pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Stemcell Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |